Kerri Fitzgerald

DocwireNews

Here are the top stories covered by DocWire News&nbsp;this week in the Hematology &amp; Oncology section. This week, the U.S. Food and Drug Administration (FDA) approved a new combination therapy for transplant-eligible patients with multiple myeloma (MM), an experimental drug showed promise for lung and kidney cancers, and more.<a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/fda-approves-darzalex-combo-for-transplant-eligible-patients-with-multiple-myeloma/">The FDA approved the combination of Darzalex&reg;</a> (daratumumab) plus Velcade&reg; (bortezomib), thalidomide, and dexamethasone for patients with&nbsp;newly diagnosed MM who are eligible for autologous hematopoietic cell transplantation.According to a&nbsp;press release&nbsp;from The North American Menopause Society, experts estimate that <a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/breastcancer-preventable-lifestylechanges/">one in three breast cancer cases could be prevented by lifestyle modifications</a>. The recommendations are being presented during The North American Menopause Society Annual Meeting in Chicago.A new study has found that patients with&nbsp;non-small cell <a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/experimental-drug-shows-promise-in-treating-lung-and-kidney-cancer/">lung cancer and&nbsp;kidney cancer&nbsp;may benefit from pegilodecakin</a>, a drug currently in clinical trials. Conducted by researchers from The University of Texas MD Anderson Cancer Center, this work found that when used in concert with pembrolizumab and nivolumab (two leading anti-PD-1 monoclonal antibodies), pegilodecakin was had therapeutic effects in these patients.<a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/tapwater-cancercases/">Drinking tap water may prove lethal</a>, as the results of a&nbsp;study&nbsp;published in&nbsp;Heliyon&nbsp;found a toxic combination of chemical pollutants in U.S. drinking water could result in more than 100,000 new cancer cases.A team from the&nbsp;University of Bath&nbsp;has recently <a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/high-throughput-screening-used-to-identify-promising-prostate-cancer-treatments/">used high-throughput screening techniques</a> to evaluate tens of thousands of compounds to identify promising&nbsp;prostate cancer drugs. These researchers, from the University&rsquo;s Departments of Chemistry and Pharmacy &amp; Pharmacology, are analyzing the &alpha;-methylacyl-CoA racemase protein as a possible target for cancer drugs.In case you missed it, more hem/onc headlines are featured below:<ul>
<li><a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/tb-vaccine-may-reduce-lung-cancer-risk/">TB Vaccine May Reduce Lung Cancer Risk</a></li>
<li><a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/breast-cancer-mortality-higherinmen/">Breast Cancer Mortality Higher in Men than Women</a></li>
<li><a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/down-syndrome-and-leukemia-whats-the-connection/">Down Syndrome and Leukemia: What&rsquo;s The Connection?</a></li>
<li><a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/colonoscopies-could-reduce-cancer-mortality/">Colonoscopies Could Reduce Cancer Mortality</a></li>
<li><a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/palliative-care-extends-survival-in-advanced-lung-cancer-patients/">Palliative Care Extends Survival in Advanced Lung Cancer Patients</a></li>
</ul>

Areef Ishani, MD

Joel M. Topf, MD, FACP

Kidney Stones With Chlorthalidone Versus Hydrochlorothiazide

NKF Spring Clinical Meetings 2025

MarkAlain Déry, DO

Eric Griggs, MD

Measles in America: An Ongoing Problem

Infectious Disease

Roger Rodby, MD

Seldin Award Winner Advocates Online Education

Latest News

Hem/Onc Roundup: FDA Approves New Myeloma Combo, Tap Water Linked to Cancer, and more

Oncology

Here are the top stories covered by DocWire News this week in the Hematology &amp; Oncology section. This week, the U.S. Food and Drug Administration (FDA) approved a new ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe